Financial Distress among US Adults with Cardiovascular and Cerebrovascular Disease History: A Nationally

Soonmyung Andrew Hwang1, Jaan K Nandwani2, Laura Katherine Stein1

  • 1Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, USA.

Insights

Individuals with cardiovascular and cerebrovascular diseases experience higher financial distress, including difficulty paying medical bills and affording medications. Targeted strategies are needed to alleviate these cost-related healthcare barriers for this population.

Area of Science:

  • Public Health
  • Health Economics
  • Cardiology

Background:

  • Cardiovascular and cerebrovascular diseases are leading causes of U.S. morbidity, mortality, and economic burden.
  • High rates of financial distress, stemming from medical costs, are reported among patients with these conditions.
  • Understanding the link between disease history and financial strain is crucial for targeted interventions.

Purpose of the Study:

  • To examine the association between cardiovascular/cerebrovascular disease history and financial distress in U.S. adults.
  • To identify specific factors contributing to financial distress within this high-risk patient group.

Main Methods:

  • Cross-sectional analysis of pooled 2021-2023 National Health Interview Survey data.
  • Financial distress measured by self-reported medical affordability and cost-related medication nonadherence.
  • Propensity score matching and multivariable logistic regression used to analyze associations.

Main Results:

  • The disease cohort showed higher prevalence of financial distress (47.1% vs. 45.9%) and increased odds of overall financial distress (OR=1.05).
  • Patients with cardiovascular/cerebrovascular disease had greater odds of problems paying medical bills (OR=1.32) and affording medications (OR=1.20).
  • Factors associated with distress in the disease cohort included female sex, Hispanic ethnicity, lower education, and lack of insurance; older age and Medicaid coverage were protective.

Conclusions:

  • Cardiovascular/cerebrovascular disease is significantly linked to increased financial distress across various aspects of healthcare costs.
  • Urgent development and implementation of targeted strategies are necessary to reduce healthcare cost barriers for individuals with these diseases.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...